About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 2354 record(s)
Req # A-2021-000715
Adverse Drug Reaction (ADR) for HYDROXYCHLOROQUINE SULFATE. Report number: E2B_03350306.Organization: Health Canada
December 2021
Req # A-2021-000746
Adverse Drug Reactions (ADRs) for. Report numbers: E2B_03830553, E2B_04005470, E2B_04005482, E2B_04010997, E2B_04015182, E2B_04017190, E2B_04029801, E2B_04077964, E2B_04086479, E2B_04088871, 000940326, E2B_03857154, E2B_03965590, E2B_03968250,…Organization: Health Canada
December 2021
Req # A-2021-000757
Adverse Drug Reaction (ADR). Report number: E2B_03995825.Organization: Health Canada
December 2021
Req # A-2021-000794
Adverse Drug Reactions (ADRs) for AMITRIPTYLINE HYDROCHLORIDE. Report numbers: 000926354, E2B_03334949.Organization: Health Canada
December 2021
Req # A-2021-000806
Adverse Drug Reactions (ADRs) for HYDROXYCHLOROQUINE SULFATE. Report numbers: E2B_03339245, E2B_03510889.Organization: Health Canada
December 2021
Req # A-2021-000812
Adverse Drug Reactions (ADRs) for HYDROXYCHLOROQUINE SULFATE. Report numbers: E2B_03501636, E2B_03500488, E2B_03484433, E2B_03452355, E2B_03477502, E2B_03478053, E2B_03482536, E2B_03278615, E2B_03324820, E2B_03380092, E2B_03285246, E2B_03400891,…Organization: Health Canada
December 2021
Req # A-2021-000813
Adverse Drug Reactions (ADRs) for IPRATROPIUM BROMIDE. Report numbers: E2B_03434660, E2B_03473185.Organization: Health Canada
December 2021
Req # A-2021-000827
Adverse Drug Reaction (ADR) for TRANDOLAPRIL. Report number: E2B_03480899.Organization: Health Canada
December 2021
Req # A-2021-000835
Adverse Drug Reaction (ADR) for SULFASALAZINE. Report number: E2B_03278682.Organization: Health Canada
December 2021
Req # A-2021-000836
Adverse Drug Reactions (ADRs) for ZOPICLONE. Report numbers: E2B_03478043, 000926738, 000927160, E2B_03408952, E2B_03424958, E2B_03428714, E2B_03481171, E2B_03453800, E2B_03456738, E2B_03452292, E2B_03448466.Organization: Health Canada
December 2021